1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Competitor Analysis: Human Growth Hormone (hGH)

Competitor Analysis: Human Growth Hormone (hGH)

  • April 2013
  • -
  • La Merie Publishing
  • -
  • 49 pages

Product description

The Competitive Intelligence Report Human Growth Hormone (hGH) as of April 2013 provides a competitor analysis in the development pipeline of biosimilar versions of somatropin and next generation biobetter/biosuperior hGH products for treatment of growth hormone deficiency (GHD) in childrens and adults and related diseases. 2012 global sales data of branded hGH products in regulated marktes are provided. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently marketed hGH products and active projects in research and development of novel hGH products. In addition, the report lists company-specific R&D pipelines of hGH products and projects Competitor projects are listed in a tabular format providing Information on:

• Drug Codes,
• Target / Mechanism of Action,
• Class of Compound,
• Company,
• Territory,
• Indication,
• R&D Stage and
• additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

Table Of Contents

Competitor Analysis: Human Growth Hormone (hGH)
Table of Contents

• 2012 Sales of Branded Somatropin Products in Regulated Markets
• 2012 Sales of Selected Somatropin Products in Non-Regulated Markets
• 1st Generation: Somatropin in Regulated Markets
• 1st Generation: Biosimilar Somatropin in Regulated Markets
• 2nd Generation: Injectable Somatropin in Slow-release Formulation in Regulated Markets
• 2nd Generation: Injectable Long-acting Somatropin in Regulated Markets
• 2nd Generation: Injection-Free Somatropin in Regulated Markets
• 1st Generation: Somatropin Products in Non-Regulated Markets
• 2nd Generation: Injectable Long-Acting Somatropin Products in Non-Regulated Markets
• Non-Medical, Legal Uses of Somatropin
• Corporate hGH RandD Pipelines

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Biopharmaceutical Market Report & Forecast (2016-2021)

Global Biopharmaceutical Market Report & Forecast (2016-2021)

  • $ 1500
  • Industry report
  • July 2016
  • by International Market Analysis Research and Consult

The global biopharmaceutical Industry has come a long way since its first drug- Humulin was approved in 1982. Today hundreds of biopharmaceuticals have already been approved and many more are in late stages ...

Biologics Market Trends and Forecasts 2016-2026

Biologics Market Trends and Forecasts 2016-2026

  • $ 3763
  • Industry report
  • July 2016
  • by Visiongain

Report Details Biological Drugs – Discover Revenue Potentials Now, Benefiting Your Authority Do you want to find how high biological drug sales can go? Visiongain’s new analysis gives you those revenue ...

Analyzing the Global Biosimilars Industry 2016

Analyzing the Global Biosimilars Industry 2016

  • $ 1100
  • Industry report
  • July 2016
  • by Aruvian's R'search

Biosimilars are the officially approved versions of biopharmaceutical products that are manufactured by a different company following the patent expiry of the original product. Also known as subsequent ...


Download Unlimited Documents from Trusted Public Sources

Biosimilar Industry in Europe

  • November 2016
    42 pages
  • Biosimilar  

  • Europe  

View report >

Biosimilar Industry in the US

  • September 2016
    28 pages
  • Biosimilar  

    Biochemical  

  • United States  

View report >

Biosimilar Statistics

  • September 2016
    124 pages
  • Biosimilar  

    Filgrastim  

  • Europe  

    United Kingdom  

    Norway  

View report >

Biosimilar Statistics

3 months ago

Related Market Segments :

Somatropin

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.